Literature DB >> 20518797

Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy.

M Bassetti1, A Parisini, A Calzi, F M Bobbio Pallavicini, G Cassola, S Artioli, M Anselmo, G Pagano, G Rezza, C Viscoli.   

Abstract

Eighty-one patients affected by the novel influenza A (H1N1), hospitalized in North-western Italy, were studied. The median age was 32 years (range 1-81 years). Fifty-six (69%) had an underlying medical condition, including lung disorders (asthma or chronic obstructive pulmonary disease) in 34% and obesity in 25%. Fifty percent of them had pneumonia, 12% were admitted to the intensive care unit and 3% died. Antiviral treatment was initiated in 75% of patients started within 48 h. Older age and lung and neurocognitive disorders were associated with severe disease and death.
© 2010 The Authors. Journal Compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 20518797     DOI: 10.1111/j.1469-0691.2010.03275.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  11 in total

Review 1.  Hospitalization Fatality Risk of Influenza A(H1N1)pdm09: A Systematic Review and Meta-Analysis.

Authors:  Jessica Y Wong; Heath Kelly; Chung-Mei M Cheung; Eunice Y Shiu; Peng Wu; Michael Y Ni; Dennis K M Ip; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2015-07-18       Impact factor: 4.897

2.  Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy.

Authors:  Maria-Teresa Gervasi; Roberto Romero; Gabriella Bracalente; Tinnakorn Chaiworapongsa; Offer Erez; Zhong Dong; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Gil Mor; Luisa Barzon; Elisa Franchin; Valentina Militello; Giorgio Palù
Journal:  J Matern Fetal Neonatal Med       Date:  2012-05-30

Review 3.  Review on the impact of pregnancy and obesity on influenza virus infection.

Authors:  Erik A Karlsson; Glendie Marcelin; Richard J Webby; Stacey Schultz-Cherry
Journal:  Influenza Other Respir Viruses       Date:  2012-02-15       Impact factor: 4.380

4.  COVID-19: what have we learned?

Authors:  Yeh-Li Ho; Anna Miethke-Morais
Journal:  J Bras Pneumol       Date:  2020-06-15       Impact factor: 2.800

5.  Natural and vaccine-mediated immunity to Salmonella Typhimurium is impaired by the helminth Nippostrongylus brasiliensis.

Authors:  Saeeda Bobat; Matthew Darby; Dunja Mrdjen; Charlotte Cook; Erin Logan; Jennifer Auret; Elizabeth Jones; Corinna Schnoeller; Adriana Flores-Langarica; Ewan A Ross; Alykhan Vira; Constantino López-Macías; Ian R Henderson; James Alexander; Frank Brombacher; William G Horsnell; Adam F Cunningham
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

Review 6.  Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

7.  Pneumonia in patients with novel influenza A (H1N1) virus in Southeastern Turkey.

Authors:  Tacettin Ornek; Funda Demirtaş Yalçın; Selami Ekin; Saban Yalçın; Mücahit Yemişen
Journal:  Wien Klin Wochenschr       Date:  2011-02-16       Impact factor: 1.704

8.  Influenza A(H1N1)pdm09-associated pneumonia deaths in Thailand.

Authors:  Charatdao Bunthi; Somsak Thamthitiwat; Henry C Baggett; Pasakorn Akarasewi; Ruchira Ruangchira-urai; Susan A Maloney; Kumnuan Ungchusak
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

9.  Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany.

Authors:  Nicola Lehners; Steffen Geis; Christoph Eisenbach; Kai Neben; Paul Schnitzler
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

10.  Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units.

Authors:  Sergio Carbonara; Giuseppe Bruno; Giuseppe Di Ciaula; Anna Donata Pantaleo; Gioacchino Angarano; Laura Monno
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.